Rochdi Bouhelal - Concepedia

Author

Rochdi Bouhelal

Novartis (Switzerland)

Also Known As

Bouhelal, Rochdi, R Bouhelal, R. Bouhelal, Rochdi Bouhelal

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical Research Centre National de la Recherche Scientifique Inserm

About

Rochdi Bouhelal is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	875
2	Health Sciences	4	4	283
3	Natural Sciences	4	4	117
4	Social Sciences	1	1	42
5	Allergy	1	1	38

Rochdi Bouhelal

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Aline Dumuis, Rochdi Bouhelal, Michèle Sebben, Molecular Pharmacology	1988	437
5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra Rochdi Bouhelal, Larbi Smounya, Joël Bockaert European Journal of Pharmacology Signal TransductionBiochemistryG Protein-coupled ReceptorMedicineAdenylate Cyclase	1988	161
A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930 Aline Dumuis, Rochdi Bouhelal, Michèle Sebben, European Journal of Pharmacology Signal TransductionFunctional SelectivityMedicineG Protein-coupled ReceptorPhysiology	1988	138
Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons Jo�l Bockaert, Aline Dumuis, Rochdi Bouhelal, Naunyn-Schmiedeberg s Archives of Pharmacology Functional SelectivityPutative Anxiolytic DrugsMedicine5-Ht1a ReceptorsPiperazine Derivatives	1987	138
High Throughput Screening Technologies for Direct Cyclic AMP Measurement Daniela Gabriel, Magali Vernier, Martin Pfeifer, Assay and Drug Development Technologies	2003	137
Expression and Characterization of a 5-oxo-6E,8Z,11Z,14Z-Eicosatetraenoic Acid Receptor Highly Expressed on Human Eosinophils and Neutrophils Carol E. Jones, Suzanne Holden, Laurent Tenaillon, Molecular Pharmacology	2003	109
G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype Klemens Högenauer, Luca Arista, Niko Schmiedeberg, Journal of Medicinal Chemistry ImmunologyImmune RegulationImmunologic MechanismCholangiopathiesMurine Gpbar1	2014	92
Blocking Metabotropic Glutamate Receptor Subtype 7 (mGlu7) via the Venus Flytrap Domain (VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior Christine E. Gee, Daniel Peterlik, Christoph Neuhäuser, Journal of Biological Chemistry	2014	74
AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization Ivo Vranesic, Silvio Ofner, Peter J. Flor, Bioorganic & Medicinal Chemistry Pharmacological CharacterizationAnti-inflammatoryPharmacologyMechanism Of ActionPharmacological Agent	2014	55
Monitoring Gq-coupled receptor response through inositol phosphate quantification with the IP-One assay Eric Trinquet, Rochdi Bouhelal, Michel Dietz Expert Opinion on Drug Discovery	2011	53

Page 1